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Although cellular uptake of vitamin E 
was initially described as a passive process, 
recent studies in the liver and brain have 
shown that SR-BI is involved in this 
phenomenon. As SR-BI is expressed at high 
levels in the intestine, the present study 
addressed the involvement of SR-BI in 
vitamin E trafficking across enterocytes. 
Apical uptake and efflux of the main dietary 
forms of vitamin E was examined using Caco-
2 TC-7 cell monolayers as a model of human 
intestinal epithelium. RRR--tocopherol 
bioavailability was compared between wild-
type mice and mice overexpressing SR-BI in 
the intestine. The effect of vitamin E on 
enterocyte SR-BI mRNA levels was measured 
by real-time quantitative RT-PCR. 
Concentration-dependent curves for vitamin 
E uptake were similar for RRR--, RRR-- 
and DL--tocopherol. RRR--tocopherol 
transport was dependent on incubation 
temperature, with a 60% reduction in 
absorption at 4°C compared to 37°C (p<0.05). 
Vitamin E flux in enterocytes was directed 
from the apical to the basal side, with a 
relative 10-fold reduction in the transfer 
process when measured in the opposite 
direction (p<0.05). Co-incubation with 
cholesterol, -tocopherol or lutein 
significantly impaired -tocopherol 
absorption. Anti-human SR-BI antibodies 
and BLT1 (a chemical inhibitor of lipid 
transport via SR-BI) blocked up to 80% of 
vitamin E uptake and up to 30 % of apical 
vitamin E efflux (p<0.05), and similar results 
were obtained for RRR--tocopherol. SR-BI 
mRNA levels were not significantly modified 
after a 24-hour incubation of Caco-2 cells 
with vitamin E. Finally, RRR--tocopherol 
bioavailability was 2.7-fold higher in mice 
overexpressing SR-BI than in wild-type mice 
(p<0.05). The present data show for the first 
time that vitamin E intestinal absorption is, at 
least partly, mediated by SR-BI. 
 
Vitamin E is a fat-soluble micronutrient 
which occurs in nature in eight different forms: 
RRR--, -, -, and -tocopherol and RRR--, -
, -, and -tocotrienol. The human diet mainly 
provides RRR--tocopherol (RRR--T) and 
RRR--tocopherol (RRR--T), while 
supplements generally supply vitamin E as DL-
-tocopherol (DL--T) or DL--tocopherol 
acetate. Although a recent study has described 
the fate of vitamin E in the human digestive tract 
(1), the major steps from micellar uptake to 
enterocyte trafficking and incorporation into 
chylomicrons are largely unknown (2). It has 
long been assumed that vitamin E, like other fat-
soluble (micro)nutrients, is absorbed by a passive 
process. However, recent data suggest that the 
absorption of fat-soluble (micro)nutrients is more 
complex than previously thought. More 
precisely, several transporters, i.e. ABC 
transporters (3), Niemann-Pick C1 Like 1 
(NPC1L1) (4), cluster determinant 13 (CD13) (5) 
and Scavenger Receptor class B type 1 (SR-BI) 
(6), have been implicated in cholesterol 
trafficking in the enterocyte, and it has recently 
been shown that the absorption of the two 
carotenoids lutein and -carotene is at least 
partly mediated by SR-BI (7,8). Interestingly, 
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recent data add support to the hypothesis of 
involvement of SR-BI in vitamin E transport in 
the enterocyte. Firstly, SR-BI is expressed at 
substantial levels in the intestine (9). Second, 
SR-BI significantly contributes to the selective 
uptake of HDL-associated vitamin E in both 
porcine brain (10) and rat pneumocytes (11). 
Third, an SR-BI analog was reported to mediate 
cellular uptake of -tocopherol in Drosophila 
(12). Fourth, vitamin E metabolism is abnormal 
in SR-BI-deficient mice (13). The objectives of 
this study were to assess whether intestinal 
absorption of vitamin E is protein-mediated, and 
to determine whether SR-BI is involved in this 
phenomenon. 
 
Materials and methods 
 
Chemicals - RRR--T ( 99% pure), DL--T ( 
98% pure) and RRR--T ( 97% pure) were 
purchased from Flucka (Vaulx-en-Velin, 
France). Carotenoids (-carotene, lycopene and 
lutein) were generously provided by DSM LTD 
(the successor of F. Hoffmann-La Roche, Basel, 
Switzerland). Tocol, used as internal standard for 
HPLC analysis, was purchased from Lara Spiral 
(Couternon, France). 2-oleoyl-1-palmitoyl-sn-
glycero-3-phosphocholine 
(phosphatidylcholine), 1-palmitoyl-sn-glycero-3-
phosphocholine (lysophosphatidylcholine), 
monoolein, free cholesterol, oleic acid, sodium 
taurocholate and pyrogallol were purchased from 
Sigma-Aldricht (Saint-Quentin-Fallavier, 
France). Sulfo-NHS-LC Biotin was purchased 
from Uptima-Interchim (Montluçon, France). 
Streptavidine agarose solution (manufactured by 
Oncogene Research Products), n-octyl--D-
glucopyranoside (manufactured by Calbiochem) 
was purchased from VWR international SAS 
(Strasbourg, France). Mouse monoclonal IgG 
raised against the external domain (amino acids 
104 – 294) of human SR-BI, also known as 
CLA-1, was purchased from BD Transduction 
Laboratories (Lexington, KY, U.S.A.). BLT1 
(blocks lipid transport 1, a chemical inhibitor of 
lipid transport mediated by SR-BI) was 
purchased from Chembridge (San Diego, CA, 
U.S.A.). Dulbecco’s modified Eagle’s medium 
(DMEM) containing 4.5 g/L glucose and 
trypsin-EDTA (500 mg/L and 200 mg/L, 
respectively) was purchased from BioWhittaker 
(Fontenay-sous-Bois, France), fetal bovine 
serum (FBS) came from Biomedia (Issy-les-
Moulineaux, France), and non-essential amino 
acids, penicillin/streptomycin and PBS 
containing 0.1 mM CaCl2 and 1 mM MgCl2 
(PBS-CM) were purchased from Gibco BRL 
(Cergy-Pontoise, France). The protease inhibitor 
cocktail was a gift from F. Tosini (Avantage 
Nutrition, Marseille, France). 
 
Preparation of tocopherol-rich micelles - For 
delivery of tocopherol to cells, mixed micelles, 
which had similar lipid composition than those 
found in vivo (14), were prepared as previously 
described (7) to obtain the following final 
concentrations: 0.04 mM phosphatidylcholine, 
0.16 mM lysophosphatidylcholine, 0.3 mM 
monoolein, 0.1 mM free cholesterol, 0.5 mM 
oleic acid, 5 to 90 µM tocopherol (1) and 5 mM 
taurocholate. Concentration of tocopherol in the 
micellar solutions was checked before each 
experiment. 
 
Preparation of tocopherol-rich emulsions - For 
delivery of tocopherol to mice, emulsions were 
prepared as follows. An appropriate volume of 
tocopherol stock solution was transferred to 
eppendorfs to obtain a final amount of 5 mg in 
each tube. Stock solution solvent was carefully 
evaporated under nitrogen. Dried residue was 
solubilized in 100 µL of Isio 4 vegetable oil 
(Lesieur, Asnières-sur-Seine, France), and 200 
µL of physiological serum were added. The 
mixture was vigorously mixed in ice-cold water 
in a sonication bath (Branson 3510, Branson) for 
15 min and used for force-feeding within 10 
min. 
 
Cell culture - Caco-2 clone TC-7 cells (15,16) 
were a gift from Dr. M. Rousset (U178 
INSERM, Villejuif, France). Cells were cultured 
in the presence of DMEM supplemented with 
20% heat-inactivated FBS, 1% non-essential 
amino acid, and 1% antibiotics (complete 
medium), as previously described (7).  
For each experiment, cells were seeded and 
grown on transwells as previously described (7) 
to obtain confluent differentiated cell 
monolayers. Twelve hours prior to each 
experiment, the medium used in apical and 
basolateral chambers was a serum-free complete 
medium.  
During preliminary tests, the integrity of the cell 
monolayers was checked by measuring trans-
epithelial electrical resistance before and after 
the experiment using a voltohmmeter fitted with 
a chopstick electrode (Millicell ERS; Millipore, 
Saint-Quentin-en-Yvelines, France). 
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Identification of transport characteristics: uptake 
and efflux measurement - At the beginning of 
each experiment, cell monolayers were washed 
twice with 0.5 mL PBS. For uptake experiments, 
the apical or basolateral side of the cell 
monolayers received the tocopherol-rich 
micelles, whereas the other side received the 
serum-free complete medium. Cells were 
incubated for 15 min at either 37°C or 4°C, 
depending on the experiment. Incubation time 
was chosen after a preliminary experiment 
measuring maximal absorption rate, in order to 
obtain sufficient amounts of absorbed tocopherol 
for accurate measurements. At the end of each 
experiment, media from each side of the cell 
monolayer were harvested. Cells were washed 
twice in 0.5 mL ice-cold PBS containing 10 mM 
taurocholate to eliminate adsorbed tocopherol, 
then scraped and collected in 2 mL PBS. 
Absorbed tocopherol was estimated as 
tocopherol found in scraped cells plus tocopherol 
found on the opposite side of the cell monolayer 
(basolateral side when micellar tocopherol was 
added to the apical side, and vice versa). 
For apical efflux experiments, the cells first 
received the tocopherol-rich micelles at the 
apical side for 60 minutes. They were then 
washed 3 times with PBS and received apical 
medium containing vitamin E acceptors, i.e. 
vitamin-E-free mixed micelles. Aliquots of 
apical and/or basolateral medium were taken at 
different times, and replaced by the same volume 
of new medium. 
All the samples were stored at –80°C under 
nitrogen with 0.5% pyrogallol as a preservative 
before tocopherol extraction and HPLC analysis. 
Aliquots of cell samples without pyrogallol were 
used to assess protein concentrations using a 
bicinchoninic acid kit (Pierce, Montluçon, 
France). 
 
Competition studies 
 
With cholesterol - RRR-- and RRR--T 
uptake was measured after incubation of 
vitamin-E-rich mixed-micelles (70.4 µM) 
containing either no cholesterol, 0.1 mM 
cholesterol (control) or 0.2 mM cholesterol.  
 
With other microconstituents - RRR-- 
and RRR--T uptake was measured after 
incubation of vitamin-E-rich mixed-micelles 
(final concentration: 40 µM) containing either no 
other microconstituent, RRR--T (final 
concentration of 40 µM when RRR--T uptake 
was measured), RRR--T (final concentration of 
40 µM when RRR--T uptake was measured), or 
carotenoids (final concentration: 6.0 µM lutein, 
2.8 µM -carotene or 0.4 µM lycopene).  
 
Involvement of proteins in tocopherol transport 
 
Test for the localization of SR-BI in 
apical or basolateral membranes of Caco-2 TC-
7 cells - Biotinylation of cell monolayers and dot 
blotting were performed as previously described 
(7). Blots were then incubated with the mouse 
anti-human SR-BI IgG at 1/1000 dilution. Anti-
mouse IgG were used as secondary antibodies at 
1/5000 dilution for visualization.  
 
Tocopherol apical transport inhibition 
by anti-human SR-BI antibody - For uptake 
experiments, cell monolayers were incubated for 
2 min with 3.75 µg/mL of anti-human SR-BI 
monoclonal antibody raised against the external 
domain before tocopherol-rich micelles were 
added. Previous experiments have shown that 
this antibody concentration allowed a maximal 
inhibition of absorption (7). Anti-human SR-BI 
antibody raised against the C-terminal domain, 
which is located at the internal side of the apical 
membrane, was used as a control at 3.75 g/mL 
(17). 
For efflux experiments, tocopherol-enriched cells 
(see previous section on uptake and efflux 
measurements) received apical medium 
containing 3.75 µg/mL of anti-human SR-BI 
antibody and vitamin-E-free mixed micelles (as 
acceptors) for up to 24 h.  
 
Tocopherol apical transport inhibition 
by BLT1 - BLT1 cytotoxicity had been controlled 
previously using a CellTiter 96 Aqueous One 
Solution assay (Promega, Madison, WI, U.S.A.) 
(7). These control experiments showed that 
BLT1 was not toxic up to 10 µM. The effect of 
BLT1 on tocopherol uptake was assessed as 
follows: cell monolayers were pretreated with 
either DMSO (control) or BLT1 at 10 µM for 1 
h. The cells then received tocopherol-rich mixed 
micelles with 10 M of BLT1, and uptake was 
measured as described above. 
For efflux experiments, tocopherol-enriched cells 
received apical medium supplemented with 
either DMSO or BLT1 at 10 µM and vitamin-E-
 4 
free mixed micelles (as acceptors) for up to 6 h. 
Efflux was measured as described above. 
 
Tocopherol bioavailability in mice 
overexpressing SR-BI in the intestine - 
Transgenic mice were created as follows: the SR-
BI cDNA was obtained by digestion of 
pRC/CMV vector by restriction enzyme Hind III 
and Xba I. The apolipoprotein C III enhancer (-
500/-890 pb)-apolipoprotein A IV promoter (-
700 pb) was excised from pUCSH-CAT 
plasmids using restriction enzymes Xba I and 
Hind III. The construct containing the 
apolipoprotein C III enhancer-apolipoprotein A 
IV promoter to the intestinal specificity and the 
1.8 kilobase cDNA fragment of murine SR-BI 
was cloned into the XbaI site of the pc DNA 1.1 
vector. A linearized fragment of the construct 
was obtained by digestion of the vector by 
restriction enzymes Sal I and Avr II, and used to 
generate transgenic mice by standard procedures 
on a B6D2 background. 
Detailed informations on the characteristics of 
SR-BI Tg mice are provided 
in the Bietrix et al's paper (18). RNA analysis 
showed that SR-BI Tg mice had a 
25 fold increase of SR-BI in the intestine as 
compared to wild type mice. 
Immunocytochemistry confirmed the intestinal 
overexpression of SR-BI in Tg 
mice and showed that the protein was located at 
the same sites than in wild 
type mice. 
The mice were housed in a temperature-, 
humidity- and light-controlled room. They were 
given a standard chow diet and water ad libitum. 
They were fasted overnight before each 
experiment. On the day of the experiment, a first 
blood sample was obtained at fasting (zero 
baseline sample) by cutting the extremity of the 
tails. The mice were then force-fed with a RRR-
-tocopherol-enriched emulsion. Additional 
blood samples were taken at 1, 2, 3, 4, 7, 10 and 
24 h after force-feeding. Plasma samples were 
stored at –80 °C until vitamin E analysis by 
HPLC. 
 
Tocopherol extraction - Tocopherol was 
extracted from 500 µL aqueous samples using 
the following method. Distillated water was 
added to sample volumes below 500 µL to reach 
a final volume of 500µL. Tocol, which was used 
as internal standard, was added to the samples in 
500 µL ethanol. The mixture was extracted once 
with one volume of hexane. The hexane phase 
obtained after centrifugation (500 g, 10 min, 
4°C) was evaporated to dryness under nitrogen, 
and the dried extract was dissolved in 100 µL 
methanol. A volume of 5-20 µL was used for 
HPLC analysis. 
 
Tocopherol analysis - RRR--, RRR--, DL--,T 
and tocol were separated using a 250  4.6 nm 
RP C18, 5 m Zorbax column (Interchim, 
Montluçon, France) and a guard column. The 
mobile phase was 100% methanol. Flow rate was 
1.5 mL/min, and the column was kept at a 
constant temperature (30°C). The HPLC system 
comprised a Dionex separation module (P680 
HPLC Pump and ASI-100 Automated Sample 
Injector, Dionex, Aix-en-Provence, France) and a 
Jasco fluorimetric detector (Jasco, Nantes, 
France). Tocopherols were detected at 325 nm 
after light emission at 292 nm, and identified by 
retention time compared with pure (>95%) 
standards. Quantification was performed using 
Chromeleon software (version 6.50 SP4 Build 
1000) comparing peak area with standard 
reference curves. All solvents used were HPLC 
grade from SDS (Peypin, France). 
 
Effect of vitamin E on SR-BI mRNA levels - 
Differentiated cell monolayers cultivated on 
filters were incubated with either 80 µM RRR--
T-rich micelles, 80 µM RRR--T-rich micelles 
or tocopherol-free micelles (controls) for 24 h. 
Total RNA was isolated from the cells using 
RNA II nucleospin™ kits (Macherey-Nagel, 
Düren, Germany). The cDNA was prepared by 
reverse transcription of 1 µg total RNA using 
random hexamers as primers. An equivalent 
volume of 5 µl of cDNA solution was used for 
quantification of specific cDNA by real-time 
quantitative RT-PCR. The sequences of the 
primers for 18S RNA, used as an internal 
standard for sample normalization, have been 
published previously (19). The sequences of the 
forward and reverse human SR-BI primers were 
5’-CGGCTCGGAGAGCGACTAC-3’ and 5’-
ATAATCCCCTGAACCCAAGGA-3’, 
respectively. 
Real-time quantitative RT-PCR reactions were 
performed in duplicate on an ABI PRISM™ 
7700 Sequence Detection System (PE Applied 
Biosystems) using SYBR green kits 
(Eurogentec, Angers, France), in line with the 
manufacturer’s instructions. A melt curve peak 
analysis was performed at the end of all real-
time PCR runs to ensure that only the correct 
 5 
product was amplified. The relative levels of SR-
BI mRNA were calculated as recommended by 
the manufacturer using the comparative ΔΔCt 
method (User Bulletin #2, ABI PRISM 7700 
Sequence Detection System, PE Applied 
Biosystems), and then analyzed as described by 
Livak and Schmittgen (20). 
 
Statistical analysis - Results are expressed as 
means ± SD. Differences between two groups of 
unpaired data were tested using the 
nonparametric Mann-Whitney U test. Values of 
p<0.05 were considered significant. All statistical 
analyses were performed using Statview 
software, version 5.0 (SAS Institute, Cary, NC, 
U.S.A.). Relationships between two variables 
were examined by regression analysis on 
KaleidaGraph version 3.6 software (Synergy 
software, Reading, PA, U.S.A.). 
  
Results 
 
Incorporation of tocopherol in mixed micelles - 
Increasing amounts of RRR--T, RRR--T or 
DL--T, corresponding to theoretical final 
concentrations ranging from 2.5-90 µM, were 
added to the lipid mixture during micelle 
preparation, and the concentrations of tocopherol 
recovered in the mixed micelles was measured. 
The incorporation of all three tocopherols 
increased linearly (data not shown).  
  
Effect of incubation time on tocopherol uptake - 
RRR--T and RRR--T absorbed by the 
differentiated monolayers increased curvilinearly 
for up to 60 min of incubation for both a high (40 
µM) and a low (2.5 µM) concentration (data not 
shown). At incubation time shorter than 15 min 
and at the low concentration, the amounts of 
tocopherol were absorbed were insufficient for 
accurate measurement. Thus, in order to remain 
as close as possible to the initial absorption rate 
and to obtain adequate tocopherol absorption, we 
decided to work at 15 min incubation. 
Competition studies were performed at 30 min, 
which approximately represents the time during 
which the bowel content remains in contact with 
duodenal cells during digestion (21). Finally, 
some absorption experiments were carried out at 
60 min to increase differences between groups. 
 
Effect of micellar tocopherol concentration on 
tocopherol absorption - Absorption of RRR--T, 
RRR--T and DL--T was not linear (Fig. 1). 
The best fits were hyperbolic curves 
y = ax/(x + b), R² > 0.99. Apparent Qmax and K 
values were calculated (Table 1). Qmax represents 
maximal amount of tocopherol absorbed, and K 
represents the concentration of micellar 
tocopherol required to reach Qmax/2. Note that 
these values likely depend on micelle 
composition. There was no significant difference 
between vitamin E species in terms of affinity for 
a potential transporter (K values). 
 
Effect of temperature and transport direction - 
Table 2 shows that there was (i) a significant 
decrease in RRR--T and RRR--T absorption at 
4°C compared to 37°C, and (ii) a drastic fall (up 
to 93.7%) in RRR--T and RRR--T absorption 
when vitamin-E-rich micelles were supplied at 
the basolateral side compared with the apical 
side. 
 
Effect of the amount of cholesterol incorporated 
in micelles with vitamin E on vitamin E 
absorption - Cholesterol is naturally present in 
micelles during digestion, but in concentrations 
that increase or decrease depending on diet and 
biliary secretion. RRR--T was significantly 
affected by micellar cholesterol concentration. 
More precisely, absorption decreased when 
micellar cholesterol concentration increased 
(Table 3). Similar results were obtained for 
RRR--T (data not shown). 
 
Effect of co-incubation with other fat-soluble 
microconstituents on vitamin E absorption - As 
shown in Table 4, co-incubation of micellar 
RRR--T with micellar RRR--T significantly 
decreased the absorption of micellar RRR--T. 
Co-incubation with lutein also significantly 
decreased RRR--T absorption. Conversely 
there was no significant effect of -carotene and 
lycopene on RRR--T absorption, but it should 
be noted that the micellar concentrations of these 
carotenoids were necessarily lower than for 
lutein due to their naturally lower solubility in 
micelles. Similar results were obtained with 
RRR--T (data not shown). 
 
Involvement of SR-BI in vitamin E transport 
across the apical membrane of the enterocyte 
 
The biotinylation experiment we 
performed demonstrated that SR-BI is mainly 
located at the apical membrane of Caco-2 TC7 
cells, according to our previous work (7). 
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Uptake experiment - Figure 2 shows that 
addition of anti-human SR-BI antibody raised 
against the external domain significantly 
decreased RRR--T and RRR--T apical 
absorption (by about 20%). Conversely, and as 
expected, the control antibody, i.e. the anti-
human SR-BI antibody raised against an internal 
domain, did not impair vitamin E absorption 
(data not shown). The specific chemical inhibitor 
of SR-BI (BLT1) also significantly decreased 
RRR--T and RRR--T absorption (by up to 
80%). 
 
 Apical efflux experiment - The apical 
effluxes of both RRR--T and RRR--T (data 
not shown) increased dramatically (approx. 
300% after 24 h) when a putative physiological 
acceptor of vitamin E, in this case vitamin-E-free 
mixed micelles, was added to the apical medium 
(Fig. 3). Adding either anti-human SR-BI 
antibody raised against the external domain or 
BLT1 at the apical side of the cells in the 
presence of vitamin-E-free mixed micelles 
significantly reduced the apical efflux of RRR--
T (Figs 4 A and B) and RRR--T (data not 
shown, but similar for this vitamin). 
 
Regulation of enterocyte SR-BI mRNA levels by 
vitamin E - SR-BI mRNA levels were not 
significantly affected by incubation of 
differentiated cell monolayers with either RRR-
-T or RRR--T (data not shown). 
 
RRR--T bioavailability in mice overexpressing 
SR-BI in the intestine - Plasma RRR--T 
response (expressed as area under the 
postprandial 0-24 h curves) after force-feeding 
with RRR--T-enriched emulsion was 
significantly higher in SR-BI Tg mice than in 
control mice: 106.9  21.0 µmol.h/L vs. 54.9  
22.5 µmol.h/L (P = 0.0062; Fig. 5A). Plasma 
RRR--T response remained significantly higher 
in SR-BI Tg mice than in wild-type mice after 
lipid adjustment of vitamin E response (35.7  
8.4 µmol.h/g of lipid vs. 17.0  6.9 µmol.h/g of 
lipid, P = 0.0062, Fig. 5B). 
  
Discussion 
 
To study in detail the mechanisms 
involved in vitamin E transport across the 
enterocyte, we used the frequently employed 
Caco-2 TC-7 cell model, which gives 
reproducible figures that correlate closely with 
human in vivo data (22). Our first result confirms 
that RRR--T, RRR--T and DL--T show 
similar absorption patterns. This is in full 
agreement with previous studies in which there 
was no intestinal discrimination between -
tocopherol stereoisomers (23) nor between - 
and -T forms (24). Taken together, the saturable 
uptake of vitamin E, the temperature dependency 
and the direction dependency strongly argue in 
favor of a protein-mediated uptake (25). 
Although it cannot be excluded that a fraction of 
vitamin E was absorbed by passive diffusion 
because of the 30-50% absorption observed at 
4°C. After having demonstrated that a least a 
fraction of vitamin E was absorbed through a 
receptor mediated process the question that arises 
is “what transporter(s) is(are) involved?”. The 
best candidate is SR-BI, as its involvement in 
vitamin E trafficking has been demonstrated in 
several tissues (10,12,13,26). The finding that 
RRR--T and RRR--T uptake in Caco-2 cells 
was inhibited by both anti-human SR-BI 
antibody and BLT1, which is a specific chemical 
inhibitor of SR-BI (27,28), is taken as initial 
evidence that SR-BI is involved in tocopherol 
uptake. The difference in inhibition efficiency 
between the antibody and the chemical inhibitor 
can be explained by the fact that the antibody 
was monoclonal, and consequently its high site 
specificity may lead to only a partial inhibition of 
SR-BI. The fact that we did not manage to fully 
inhibit tocopherol absorption suggests that other 
means of transport (passive diffusion or other 
transporters) are involved. In order to further 
examine the involvement of SR-BI in tocopherol 
absorption, we compared tocopherol 
bioavailability between wild-type mice and mice 
overexpressing SR-BI in the intestine. To do this, 
we used RRR--T instead of RRR--T, for three 
reasons. First, as shown in this study in Caco-2 
cells and as previously reported in the clinical 
study by Traber et al. (29), there is no intestinal 
discrimination between RRR--T and RRR--T 
making it possible to choose between either of 
these isomers. Second, mice bred in-house had 
RRR--T plasma concentrations close to zero, 
making RRR--T equivalent to a tracer to 
measure newly absorbed tocopherol. Finally, 
since hepatic -TTP discriminates between 
tocopherol isomers and resecretes more -T than 
-T in VLDL, using -tocopherol generates less 
contamination of plasma tocopherol by 
tocopherol from hepatic origin, and thus provides 
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a better evaluation of tocopherol secreted by the 
intestine, i.e. newly-absorbed. The results 
obtained in mice provide further evidence that 
SR-BI is involved in tocopherol absorption. 
Having obtained evidence that SR-B1 is involved 
in the apical uptake of tocopherols, and given 
that this transporter is involved in both lipid 
uptake and efflux (30), the obvious question was 
“is this transporter involved in the apical efflux 
of tocopherol as well?”. The fact that both anti-
human SR-BI antibody and BLT1 inhibited 
tocopherol efflux from enterocytes to the apical 
side suggests that SR-BI also plays a role in 
intestinal tocopherol reverse transport. 
Given that the main dietary sources of 
vitamin E are RRR- and RRR- tocopherol, and 
that both vitamers are transported through the 
SR-BI, we  raised the question of whether there 
was competition between these two forms of 
vitamin E. This is an important issue as -
tocopherol has different biological properties to 
-tocopherol, and it has been suggested that a 
high consumption of vitamin E supplements, 
which mostly contain -tocopherol, may impair 
-tocopherol bioavailability, which would 
explain the disappointing results of large-scale 
clinical trials designed to evaluate the effects of 
vitamin E on cardiovascular diseases (31). The 
significant inhibition of RRR--T absorption 
when 40 M RRR--T was added (and vice 
versa), together with the finding that -
tocopherol concentrations in the human gut range 
between 100-600 M following the intake of a 
440 mg vitamin E supplement (1), show that 
competition between these forms of vitamin E 
likely occurs in vivo. Because SR-BI is also 
involved in the intestinal uptake of lutein (7), a 
carotenoid which, like tocopherol, is an 
isoprenoid, it is possible that carotenoids may 
impair tocopherol absorption. We therefore 
performed competition studies between RRR--
T or RRR--T and carotenoids. These 
experiments showed that lutein, but not -
carotene and lycopene, impaired tocopherol 
absorption. This difference can be explained by 
the necessarily lower concentration of lycopene 
and -carotene able to have been incorporated 
into micelles (lutein is more soluble in micelles 
than the two other carotenoids). These results 
suggest that cholesterol, carotenoids and vitamin 
E may compete for transport by SR-BI. This is 
consistent with in vivo studies which have shown 
that vitamin E decreases canthaxanthin 
absorption in the rat (32), and that diet 
supplementation with 400 IU -T per day 
reduces serum concentrations of - and -T in 
humans (33). 
 
While the physiopathological 
consequences of our findings remain unknown, 
we suggest that inter-individual variations in SR-
BI expression or efficiency may explain the 
highly significant inter-individual variability in 
tocopherol absorption (34).   
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Figure legends 
 
Fig. 1: Effect of micellar tocopherol concentration on tocopherol absorption by differentiated 
Caco-2 TC-7 cell monolayers at 37°C. The apical side received FBS-free medium containing either 
RRR--T (), RRR--T () or DL--T () -rich mixed micelles, and the basolateral side received 
FBS-free medium. Incubation time was 15 min. Data are means ± SD of 3 assays. Tocopherol 
absorbed = tocopherol recovered in the scraped cells + tocopherol recovered in the basolateral 
medium. 
 
Fig. 2: Effect of anti-human SR-BI antibody and BLT1 on RRR--T and RRR--T absorption 
by differentiated Caco-2 TC-7 monolayers. 
The apical sides of the cell monolayers were preincubated for 60 min with either the anti-human SR-
BI antibody raised against the external domain at 3.75 µg/mL or BLT1 at 10 µM, and they then 
received FBS-free medium containing either RRR--T () or RRR--T () -enriched mixed micelles 
at 40 µM. The basolateral sides received FBS-free medium. Incubation time was 60 min. Data are 
means ± SD of 3 assays. An asterisk indicates a significant difference with the control (assay 
performed with control antibody and without BLT1). 
 
Fig. 3: Effect of a physiological acceptor of vitamin E on RRR--T apical efflux by 
differentiated Caco-2 TC-7 cell monolayers.  
Cells were enriched with RRR--T (see experimental procedures), and the apical side then received 
either FBS-free medium () or FBS-free medium containing tocopherol-free mixed micelles as 
physiologiocal acceptor (). The basolateral side received FBS-free medium. Data are means ± SD of 
3 assays.  
 
Fig. 4: Effect of anti-human SR-BI antibody and BLT1 on RRR--T apical efflux by 
differentiated Caco-2 TC-7 cell monolayers. 
Cells were enriched in RRR--T, and the apical side then received either FBS-free medium 
containing tocopherol-free-mixed micelles () or the same mixture plus anti-human SR-BI antibody 
(, A) or plus BLT1 (, B). The basolateral side received FBS-free medium. Aliquots of apical 
medium were taken at different times and replaced by the same volume of new medium. Data are 
means ± SD of 3 assays. An asterisk indicates a significant difference with the control (assay 
performed without antibody or inhibitor (). 
 
Fig. 5: Plasma -tocopherol response in wild-type mice and in mice overexpressing SR-BI in the 
intestine. 
Mice were force-fed with an RRR--T enriched emulsion. Data are means ± SD, n = 6 for control 
mice () and 5 for transgenic mice (, SR-BI Tg).  
A: Plasma RRR--T. B: Plasma RRR--T corrected for plasma lipids (cholesterol plus phospholipids 
plus triglycerides). 
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Tables 
 
 
Table 1. Parameters of tocopherol absorption as a function of micellar tocopherol concentrations 
in differentiated Caco-2 TC-7 cell monolayers. 
 
Vitamin E species 
Apparent Qmax 
(nmole tocopherol 
absorbed/mg of protein) 
Apparent K 
(M) 
RRR--T 
RRR--T 
DL--T 
7.5  0.6 
6.5  0.5 
5.6  0.7 
84.3  9.9 
83.9  11.5 
88.3  15.2 
 
Tocopherol uptake was measured at 37°C after apical micellar tocopherol delivery in increasing 
concentrations. Incubation time was 15 min. Best fitting curves were hyperbolic curves y = ax/(b+x). 
Qmax represents the maximal amount of tocopherol absorbed, and K represents the concentration of 
micellar tocopherol required to reach Qmax/2. Data are means ± SD of 3 assays. 
 
 
Table 2. Effect of temperature and transport direction on RRR--tocopherol and RRR--
tocopherol absorption by differentiated Caco-2 TC-7 cell monolayers. 
 
RRR--tocopherol absorption 
(% of control) 
RRR--tocopherol absorption 
(% of control) 
RRR--T 
micellar 
concentration 
4°C 
Basolateral to 
apical 
RRR--T 
micellar 
concentration 
4°C 
Basolateral to 
apical 
15 µM 
31 µM 
52 µM 
29.5  6.9 * 
46.4  9.6 * 
42.0  8.0 * 
6.3  0.0 * 
6.6  2.5 * 
6.5  0.9 * 
19 µM 
41 µM 
88 µM 
48.6  5.7 * 
46.5  4.9 * 
50.0  18.2 * 
9.3  0.5 * 
6.6  1.6 * 
8.7  0.1 * 
 
Tocopherol absorption (pmol/mg of protein) was measured at 37°C after apical micellar tocopherol 
delivery (control = 100%). Tocopherol uptake at 4 °C and tocopherol uptake following addition of 
micellar tocopherol in the basolateral chamber were compared to absorptions measured with vitamin 
E-rich micelles at the same micellar concentration at 37°C and in the apical to basolateral direction. 
Incubation time was 15 min. Data are means ± SD of 3 assays. An asterisk indicates that the value 
was significantly different to the control. 
 
 
Table 3. Effect of micellar cholesterol concentration on micellar RRR--tocopherol absorption 
by differentiated Caco-2 TC-7 cell monolayers. 
 
Micellar cholesterol concentration 
RRR--T absorption 
(% of control) 
0.0 mM 
0.1 mM 
0.2 mM 
   140.3  13.1 * 
100.0  12.6 
  93.3  10.7 
 
The apical side received FBS-free medium containing vitamin-E-rich mixed micelles (70.4 µM) with 
either no cholesterol, 0.1 mM cholesterol (control) or 0.2 mM cholesterol. The basolateral side 
received FBS-free medium. Incubation time was 30 min. Data are means ± SD of 3 assays. An 
asterisk indicates a significant difference with the control. 
 
 12 
 
Table 4. Effect of RRR--tocopherol and carotenoids on RRR--tocopherol absorption by 
differentiated Caco-2 TC-7 cell monolayers. 
 
Experimental conditions 
RRR--T absorption 
(% of control) 
40 µM RRR--T + 40 µM RRR--T 
40 µM RRR--T + 6.0 µM lutein 
40 µM RRR--T + 2.8 µM -carotene 
40 µM RRR--T + 0.4 µM lycopene 
   59.5  11.9* 
 78.9  6.7* 
 80.6  10.1 
97.0  0.7 
 
The apical side received FBS-free medium containing RRR--T-rich mixed micelles (40 µM) plus 
mixed micelles containing either no other microconstituent, RRR--T, or carotenoids. The basolateral 
side received FBS-free medium. Incubation time was 30 min. Data are means ± SD of 3 assays. An 
asterisk indicates a significant difference with the control (RRR--T-rich micelles plus 
microconstituent-free mixed micelles). 
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Figures 
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Figure 3 
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Figure 4 
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